# OnCo record starton-holdings (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/starton-holdings/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "starton-holdings" ;
  schema:name "Starton Holdings"@en ;
  schema:alternateName "Starton Holdings, Inc."@en, "Starton Therapeutics"@en, "Starton Therapeutics, Inc"@en, "Starton Therapeutics Inc."@en ;
  schema:description "Starton is a New Jersey company that gives existing cancer medicines continuously, through a small pump under the skin or a slow-release tablet, instead of as a daily dose. Its lead product, STAR-LLD, is a continuous low-dose form of lenalidomide being tested in multiple myeloma that has come back or stopped responding."@en ;
  schema:url <https://onco.cc/companies/starton-holdings/>, <https://www.startontx.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/2049977/000121390026113388/ea0225405-18.htm>, <https://www.startontx.com/>, <https://clinicaltrials.gov/study/NCT06087653> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/star-lld/> ;
  onco:trials <https://onco.cc/trials/nct06087653/> .